SLIDE 22 Philip Powell – Non Executive Director
Over 15 years experience in investment banking specialising in capital raisings, IPOs, mergers and acquisitions and other successful corporate finance assignments across a diverse range of sectors including pharmaceuticals, financial services, food and agriculture. He spent 10 years in senior financial roles at OAMPS Ltd, an ASX listed financial services group and 10 years in audit with Arthur Andersen & Co. in Australia and the U.S.
Paul Brennan – Chief Executive Officer
Paul has extensive knowledge, exposure and understanding of the health system through his clinical background and commercial exposure with various multinational companies. He has co-ordinated the marketing, global strategy development, new product development and regulatory processes for the Asia-Pacific region for industry leading organisations in relation to medical products and devices. Paul has an intimate knowledge of the manufacturing / production processes. Previously he was the Marketing Director Australia and New Zealand and Sales Director New Zealand for Smith and Nephew Healthcare from 2008 to his commencement with PolyNovo in February 2015. Paul holds a Masters of Business Administration (MBA) from Swinburne University and a Bachelor of Science (Nursing) degree from the University of New England.
Ms Andrea Goldie - CFO and Company Secretary
Andrea has over 13 years corporate governance experience with multinational companies within the Pharmaceutical and Health-care industries. Her areas of expertise include financial accounting, statutory reporting, auditing and tax compliance. These skills have been applied across a number of geographic regions including Europe, Middle East, Africa, Asia Pacific and North America. Ms Goldie is a Chartered Accountant; Chartered Tax Adviser and has a Bachelors of Economics, Finance and a MBA.
Dr Tim Moore - Principle Scientist
Tim holds a Bachelor of Applied Science (Chemistry) degree with honours and PhD. Dr. Moore’s PhD dissertation was in the field of biodegradable polyurethanes; the title was “Design and Synthesis of Biodegradable Thermoplastic Polyurethanes for Tissue Engineering”. He has been with PolyNovo since its inception and is a co-inventor of some of the variants of NovoSorb™. He developed a novel range of biodegradable chain extenders which is included in several of PolyNovo’s patent applications. Dr. Moore is also responsible for the maintenance of PolyNovo’s extensive Intellectual Property Portfolio. He was a co-recipient of the CSIRO Molecular Science Divisional Strategic Action Plan Award for Innovation (2004) and of the CSIRO medal in Research Achievement category (2005).
Dr Paul Cacioli - Commercial Scientist
Paul has over 30 years experience in leading Research & Development teams, conversion of products to large scale manufacturing and enhancing process design. Dr Cacioli is focused on our production processes to drive efficiency and scale. Paul’s experience building and commissioning production plants with Ansell Ltd, Gale Pacific and Textor enhances PolyNovo’s ability to accelerate both production of BTM and the delivery of new products. He has a PhD in Organic Chemistry.
Board and Senior Executives (continued)
21
For personal use only
